BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for COBAS INTEGRA 400/400 plus systems, Roche

Product group In-vitro diagnostics
Reference 04263/07

Corrective action of Roche Diagnostics because of carry-over from LDL-Cholesterol assay to Lipase assay on COBAS INTEGRA 400/400 plus and from LDL-Cholesterol assay to the Lipase assay on cobas c 111. The customers were informed about the problem and how to avoid it.

Corrective action for COBAS INTEGRA 400/400 plus systems, Roche , Download_VeroeffentlichtAm_EN PDF, 336KB, File does not meet accessibility standards

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK